Skip to main content
J.G.Chemicals Limited logo

J.G.Chemicals Limited — Investor Relations & Filings

Ticker · JGCHEM ISIN · INE0MB501011 LEI · 984500BA5C0EB1C43F48 BSE.NS Manufacturing
Filings indexed 192 across all filing types
Latest filing 2026-01-05 Regulatory Filings
Country IN India
Listing BSE.NS JGCHEM

About J.G.Chemicals Limited

https://jgchem.com/

J.G. Chemicals Limited is a specialized manufacturer of Zinc Oxide, utilizing the French Process to produce a wide range of grades for diverse industrial applications. The company primarily serves the tire and rubber industry, where its products function as essential vulcanizing agents. Beyond rubber, its portfolio supports sectors including ceramics, paints and coatings, pharmaceuticals, cosmetics, and agriculture. As a significant producer by capacity, the firm emphasizes high-purity outputs and technical consistency. Its operations focus on supplying high-quality chemical components to a global customer base, supported by advanced manufacturing facilities designed to meet rigorous international quality standards and specific client formulations.

Recent filings

Filing Released Lang Actions
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st December 2025. It is addressed to stock exchanges and certifies that details of securities dematerialized/rematerialized during the quarter have been furnished to the stock exchanges. The document is a compliance certificate related to share transfer and depository services, not a financial report or detailed filing. It is short (3634 characters) and primarily a certification letter. According to the Certification Rule, such officer certifications or compliance certificates should be classified as Regulatory Filings (RNS).
2026-01-05 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the closure of the trading window for insiders due to upcoming financial results. It references the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, and specifies the period during which insiders cannot trade shares, linked to the announcement of un-audited quarterly financial results. The document does not contain any financial data or results itself, nor does it announce or attach a report. Instead, it is an announcement related to compliance and insider trading restrictions ahead of a financial disclosure. This type of document is best classified as a Regulatory Filing (RNS) because it is a regulatory compliance announcement that does not fit into other specific categories like earnings release or interim report.
2025-12-23 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges disclosing the schedule of an upcoming analyst/institutional investor meeting. It references compliance with SEBI regulations about disclosure but does not contain any financial data, report, or detailed presentation. It explicitly states that no unpublished price sensitive information will be shared. The document is short (1757 characters) and serves as an announcement of a meeting schedule rather than the meeting content or transcript. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and disclosure rather than an investor presentation or call transcript.
2025-12-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (NSE and BSE) disclosing the schedule of an upcoming Analyst/Institutional Investor meeting. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, indicating it is an official regulatory disclosure. The content is about announcing the schedule of a meeting, explicitly stating no unpublished price sensitive information will be shared. The document length is short (1766 characters), and it does not contain any financial data, report content, or detailed presentation materials. It is not a report itself but an announcement related to investor relations. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-11-28 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of an earnings conference call held on November 17, 2025, discussing the financial performance for the 2nd quarter and half year ended September 30, 2025. It includes management presentations, financial results, operational updates, and a Q&A session with analysts and investors. The content is consistent with a full transcript of a conference call rather than a brief earnings release or a summary. The presence of detailed financial figures, management commentary, and Q&A confirms it is a Call Transcript (CT).
2025-11-21 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the submission of an audio recording of an earnings call held on 17th November 2025. It references the unaudited financial results for the quarter ended 30th September 2025. The document does not contain the transcript or detailed financial data itself but rather informs about the availability of the audio recording on the company's website. The document length is short (1168 characters) and serves as an announcement or notification rather than the actual earnings release or call transcript. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement about the earnings call recording availability, not the full transcript or earnings release.
2025-11-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.